205 related articles for article (PubMed ID: 9641885)
1. Prognostic factors in ductal pancreatic cancer.
Yeo CJ; Cameron JL
Langenbecks Arch Surg; 1998 Apr; 383(2):129-33. PubMed ID: 9641885
[TBL] [Abstract][Full Text] [Related]
2. [Pancreatic carcinoma].
Böhmig M; Rosewicz S
Z Gastroenterol; 2004 Mar; 42(3):261-8. PubMed ID: 15022114
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer.
Yeo TP; Hruban RH; Leach SD; Wilentz RE; Sohn TA; Kern SE; Iacobuzio-Donahue CA; Maitra A; Goggins M; Canto MI; Abrams RA; Laheru D; Jaffee EM; Hidalgo M; Yeo CJ
Curr Probl Cancer; 2002; 26(4):176-275. PubMed ID: 12399802
[No Abstract] [Full Text] [Related]
4. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
Kawaida H; Fujii H
Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
[No Abstract] [Full Text] [Related]
5. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis of veteran patients with pancreatic cancer.
Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
[TBL] [Abstract][Full Text] [Related]
10. Tumor-node-metastasis staging of pancreatic adenocarcinoma.
Katz MH; Hwang R; Fleming JB; Evans DB
CA Cancer J Clin; 2008; 58(2):111-25. PubMed ID: 18272835
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant treatment of pancreatic cancer].
Michalski CW; Kleeff J; Jäger D; Friess H; Büchler MW
Dtsch Med Wochenschr; 2007 Apr; 132(15):803-7. PubMed ID: 17427090
[No Abstract] [Full Text] [Related]
12. [Oncologic risk in pylorus preservation in resection of ductal pancreas carcinoma].
Gerdes B; Ramaswamy A; Bartsch D; Rothmund M
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1087-9. PubMed ID: 9574341
[TBL] [Abstract][Full Text] [Related]
13. Resection and radiochemotherapy of pancreatic cancer--the future?
Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
[TBL] [Abstract][Full Text] [Related]
14. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.
Fortner JG; Klimstra DS; Senie RT; Maclean BJ
Ann Surg; 1996 Feb; 223(2):147-53. PubMed ID: 8597508
[TBL] [Abstract][Full Text] [Related]
15. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.
Basturk O; Saka B; Balci S; Postlewait LM; Knight J; Goodman M; Kooby D; Sarmiento JM; El-Rayes B; Choi H; Bagci P; Krasinskas A; Quigley B; Reid MD; Akkas G; Maithel SK; Adsay V
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1187-95. PubMed ID: 26362048
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic approaches of adenocarcinoma of the exocrine pancreas. Trends in 1997].
Eschwège F
Cancer Radiother; 1997; 1(5):532-6. PubMed ID: 9587385
[TBL] [Abstract][Full Text] [Related]
17. [Combined locoregional therapeutic strategy in locally advanced cancers of the pancreas].
Manivit P; Polo R
Ann Chir; 1998; 52(1):100. PubMed ID: 9752423
[No Abstract] [Full Text] [Related]
18. Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma.
Nakagawa K; Akahori T; Nishiwada S; Nagai M; Nakamura K; Tanaka T; Tamamoto T; Ohbayashi C; Hasegawa M; Kichikawa K; Ikeda N; Sho M
Langenbecks Arch Surg; 2018 Sep; 403(6):693-700. PubMed ID: 30218193
[TBL] [Abstract][Full Text] [Related]
19. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
[TBL] [Abstract][Full Text] [Related]
20. [Current standards in the treatment of pancreatic cancer].
Pelzer U; Riess H
Dtsch Med Wochenschr; 2015 Dec; 140(24):1813-6. PubMed ID: 26625229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
